Resmed (RMD)

Resmed (RMD) Financial Statements


Resmed Financial Overview

Resmed's market cap is currently ―. The company's EPS TTM is $6.147; its P/E ratio is 25.97; and it has a dividend yield of 1.14%. Resmed is scheduled to report earnings on January 25, 2024, and the estimated EPS forecast is $1.78. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 1.10B$ 624.08M$ 1.12B-$ 950.29M
Gross Profit$ 600.06M$ -342.16M$ 1.12B-$ 540.81M
EBIT$ 287.15M$ 324.18M$ 289.38M-$ 275.74M
EBITDA$ 340.59M$ 379.38M$ 342.17M-$ 319.77M
Net Income Common Stockholders$ 244.38M$ 229.66M$ 232.50M-$ 210.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 209.10M$ 227.89M$ 227.89M$ 0.00$ 207.16M
Total Assets$ 6.74B$ 6.75B$ 6.71B-$ 5.18B
Total Debt$ 1.50B$ 1.58B$ 1.72B$ 0.00$ 930.63M
Net Debt$ 1.29B$ 1.35B$ 1.50B$ 0.00$ 723.47M
Total Liabilities$ 2.49B$ 2.62B$ 2.78B-$ 1.74B
Stockholders Equity$ 4.25B$ 4.13B$ 3.93B$ 0.00$ 3.43B
Cash Flow-
Free Cash Flow$ 245.42M$ 198.72M$ 251.34M$ 96.97M$ 12.29M
Operating Cash Flow$ 286.28M$ 237.46M$ 282.56M-$ 44.66M
Investing Cash Flow$ -148.98M$ -46.52M$ -28.10M-$ -58.81M
Financing Cash Flow$ -151.13M$ -188.59M$ -279.56M-$ -41.88M
Currency in USD

Resmed Earnings and Revenue History

Resmed Debt to Assets

Resmed Cash Flow

Resmed Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis